Nose Bleeds



Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT)


Condition:   Hemorrhagic Hereditary Telangiectasia (HHT)
Interventions:   Drug: Protopic® (Tacrolimus) 0.1% ointment;   Drug: Placebo
Sponsor:   Hospices Civils de Lyon
Not yet recruiting - verified May 2017


Carotid Intima Media Thickness (CIMT) in Epistaxis


Conditions:   Epistaxis;   Atherosclerosis
Intervention:   Diagnostic Test: Ultrasound
Sponsor:   University of Zurich
Recruiting - verified March 2017


Nasotracheal Intubation Over a Bougie


Conditions:   Nasotracheal Intubation;   Nasal Bleeding
Interventions:   Procedure: Nasotracheal intubation over a bougie;   Procedure: Conventional Nasotracheal Intubation
Sponsor:   University of Iowa
Completed - verified December 2016


Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department


Condition:   Epistaxis
Interventions:   Drug: Tranexamic Acid;   Drug: 0.9% Sodium Chloride
Sponsor:   University of California, Davis
Recruiting - verified February 2017


Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT


Conditions:   Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Interventions:   Drug: Mupirocin;   Other: Placebo
Sponsor:   Hospital Italiano de Buenos Aires
Not yet recruiting - verified November 2016


Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children


Condition:   Lacrimal Duct Obstruction
Intervention:   Procedure: "pushed" mono-canaliculonasal intubation
Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild
Recruiting - verified February 2017


Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)


Conditions:   Hereditary Hemorrhagic Telangiectasia (HHT);   Epistaxis
Interventions:   Drug: Floseal;   Other: Packing
Sponsors:   St. Michael's Hospital, Toronto;   The Ottawa Hospital
Recruiting - verified January 2017


Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)


Condition:   Hemorrhagic Hereditary Telangiectasia (HHT)
Interventions:   Drug: Timolol nasal spray;   Drug: Placebo nasal spray
Sponsor:   Hospices Civils de Lyon
Recruiting - verified November 2016


Microporous Polysaccharide Hemospheres Epistaxis


Condition:   Epistaxis
Interventions:   Device: Microporous Polysaccharide Hemospheres;   Device: Nasal Tampon
Sponsor:   Emory University
Withdrawn - verified January 2017


Intranasal Bevacizumab for HHT-Related Epistaxis


Conditions:   HHT;   Hereditary Hemorrhagic Telangiectasia;   Epistaxis;   Nose Bleeds;   Nasal Bleeding
Interventions:   Drug: Bevacizumab;   Drug: Placebo (Saline)
Sponsor:   Stanford University
Recruiting - verified April 2017


The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.


Conditions:   Epistaxis;   Blood Pressure
Interventions:   Drug: Oxymetazoline 0.05%;   Drug: Phenylephrine 0.25%;   Drug: Lidocaine 1% plus epinephrine 1:100,000;   Drug: Bacteriostatic 0.9% NaCL
Sponsor:   Mayo Clinic
Recruiting - verified August 2016

Refine Your Search Advanced Search